Hard to Treat Diseases Inc HTDS

$0.00 0.00 (0.00%)
View Full Chart
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover HTDS, but with our powerful screener, you can find stocks in the same sector, industry, or style and filter on our unbiased ratings and valuation metrics.

Trading Information

Previous Close Price
$0.00
Day Range
$0.00–0.00
52-Week Range
$0.00–0.00
Bid/Ask
— / —
Shares Outstanding
—
Market Cap
$5,482.34
Volume/Avg
300,000 / 1M

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
—
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Hard to Treat Diseases Inc operates medical and cosmetics company in Europe, and Mainland China. It is s also in the process of developing its own stem cell bank.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
—
Total Number of Employees
—

Valuation

Metric
HTDS
Price/Earnings (Normalized)
—
Price/Book Value
—
Price/Sales
—
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
HTDS
Quick Ratio
—
Current Ratio
—
Interest Coverage
—
Quick Ratio
No chart available

Profitability

Metric
HTDS
Return on Assets (Normalized)
—
Return on Equity (Normalized)
—
Return on Invested Capital (Normalized)
—
Return on Assets
No chart available

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Vertex Pharmaceuticals Inc
VRTX
LOCK|Zzd$yCLOCK|#S<G$133B
Regeneron Pharmaceuticals Inc
REGN
LOCK|xg%dfTLOCK|!VjQ$83B
Moderna Inc
MRNA
LOCK|>hwFdqLOCK|Pjp$80B
argenx SE ADR
ARGX
LOCK|<!$@^mxLOCK|YPL$55B
BeOne Medicines Ltd ADR
ONC
LOCK|<bn>T$qLOCK|z<D$45B
Alnylam Pharmaceuticals Inc
ALNY
LOCK|$<^&>lVLOCK|pJG@$$30B
Royalty Pharma PLC Class A
RPRX
LOCK|P>%DLSrLOCK|%pDxL$28B
Incyte Corp
INCY
LOCK|c!ZHqhLOCK|f^$23B
BioNTech SE ADR
BNTX
LOCK|%#YWxxLOCK|yN$22B
Jazz Pharmaceuticals PLC
JAZZ
LOCK|Hf@h?>wLOCK|b#s$14B

Sponsor Center